Table 6 Antimicrobial activity of the synthesized aryl imidazole compounds (7a-t) Sharma et al. [17]
From: Synthesis and therapeutic potential of imidazole containing compounds
Compounds | Diameter of zone of inhibition (mm) Bacterial strains | |||
|---|---|---|---|---|
Gram positive bacteria | Gram negative bacteria | |||
S. aureus | B. subtilis | E. coli | K. pneumoniae | |
7a | 5.9 (50) | 6.9 (50) | 7.2 (50) | 8.1 (50) |
7b | 5.1 (25) | 5.5 (25) | 8.1 (50) | 8.9 (50) |
7c | 8.6 (25) | 8.4 (25) | 9.2 (12.5) | 9.5 (12.5) |
7d | 13.1 (50) | 12.5 (25) | 11.9 (25) | 12.5 (6.2) |
7e | 9.1 (25) | 8.8 (50) | 7.6 (100) | 7.8 (100) |
7f | 5.7 (100) | 5.9 (100) | 6.6 (50) | 6.9 (50) |
7g | 12.5 (50) | 12.1 (25) | 11.9 (25) | 11.6 (25) |
7h | 11.9 (50) | 11.3 (25) | 10.9 (100) | 10.7 (50) |
7i | 12.1 (25) | 13.8 (50) | 14.3 (25) | 12.5 (50) |
7j | 13.1 (25) | 12.3 (25) | 15.4 (12.5) | 11.8 (25) |
7k | 11.2 (50) | 12.4 (25) | 13.5 (12.5) | 9.1 (50) |
7l | 6.2 (100) | 7.2 (100) | 9.2 (50) | 7.5 (50) |
7m | 7.2 (100) | 8.7 (50) | 10.2 (50) | 10.3 (25) |
7n | 10.3 (25) | 12.4 (12.5) | 14.5 (6.2) | 13.3 (12.5) |
7o | 12.3 (50) | 13.6 (25) | 14.6 (25) | 14.6 (25) |
7p | 9.1 (100) | 8.3 (100) | 9.1 (50) | 10.2 (25) |
7q | 6.1 (100) | 7.4 (100) | 8.3 (50) | 6.9 (50) |
7r | 7.3 (100) | 7.4 (100) | 9.5 (50) | 9.7 (50) |
7s | 13.2 (25) | 14.5 (12.5) | 14.6 (12.5) | 11.5 (25) |
7t | 12.4 (25) | 12.7 (25) | 13.1 (50) | 11.1 (50) |
Ciprofloxacin | 18 (12.5) | 19 (6) | 19 (12.5) | 17 (6) |